Zhangzhou Pientzehuang Pharmaceutical | 600436 - Sales Revenues

Stock Price
139.25
Daily Change
-1.06 -0.76%
Monthly
-8.69%
Yearly
-32.01%
Q2 Forecast
138.99

Zhangzhou Pientzehuang Pharmaceutical reported CNY2.88B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Moderna USD 678M 342M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sh Fosun Pharma CNY 9.81B 2.35B Mar/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Wuxi Apptec CNY 12.6B 160M Dec/2026
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025